Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis.

7 O), while exhibiting a highly significant negative correlation (p < 0.001) with the sensitivity of Selumetinib (Fig. 7 I) and ARRY-162 (Fig. 7 P).

also in 132,142 other papers